Leqselvi

Active Ingredient(s): Deuruxolitinib Phosphate
FDA Approved: * July 25, 2024
Pharm Company: * SUN PHARM INDS
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Leqselvi 8 mg Oral Tablet, Film Coated
NDC: 47335-108
Labeler:
Sun Pharmaceutical Industries Inc